BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 22727937)

  • 21. Magnocellular and parvocellular pathway mediated luminance contrast discrimination in amblyopia.
    Zele AJ; Wood JM; Girgenti CC
    Vision Res; 2010 May; 50(10):969-76. PubMed ID: 20211198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Magnocellular and parvocellular visual pathway contributions to visual field anisotropies.
    McAnany JJ; Levine MW
    Vision Res; 2007 Aug; 47(17):2327-36. PubMed ID: 17662333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spatial frequencies used in Landolt C orientation judgments: relation to inferred magnocellular and parvocellular pathways.
    McAnany JJ; Alexander KR
    Vision Res; 2008 Nov; 48(26):2615-24. PubMed ID: 18374385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inferred retinal mechanisms mediating illusory distortions.
    Puts MJ; Pokorny J; Smith VC
    Vis Neurosci; 2004; 21(3):321-5. PubMed ID: 15518207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Marked selective impairment in autism on an index of magnocellular function.
    Greenaway R; Davis G; Plaisted-Grant K
    Neuropsychologia; 2013 Mar; 51(4):592-600. PubMed ID: 23333905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Visual evoked spread spectrum analysis (VESPA) responses to stimuli biased towards magnocellular and parvocellular pathways.
    Lalor EC; Foxe JJ
    Vision Res; 2009 Jan; 49(1):127-33. PubMed ID: 18977382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional loss in the magnocellular and parvocellular pathways in patients with optic neuritis.
    Cao D; Zele AJ; Pokorny J; Lee DY; Messner LV; Diehl C; Ksiazek S
    Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):8900-7. PubMed ID: 22016061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contrast sensitivity mediated by inferred magno- and parvocellular pathways in type 2 diabetics with and without nonproliferative retinopathy.
    Gualtieri M; Bandeira M; Hamer RD; Damico FM; Moura AL; Ventura DF
    Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):1151-5. PubMed ID: 21051718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Magnocellular and Parvocellular Mediated Luminance Contrast Discrimination in Severe Alcohol Use Disorder.
    Creupelandt C; Maurage P; Lenoble Q; Lambot C; Geus C; D'Hondt F
    Alcohol Clin Exp Res; 2021 Feb; 45(2):375-385. PubMed ID: 33349930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychophysical analysis of contrast processing segregated into magnocellular and parvocellular systems in asymptomatic carriers of 11778 Leber's hereditary optic neuropathy.
    Gualtieri M; Bandeira M; Hamer RD; Costa MF; Oliveira AG; Moura AL; Sadun F; De Negri AM; Berezovsky A; Salomão SR; Carelli V; Sadun AA; Ventura DF
    Vis Neurosci; 2008; 25(3):469-74. PubMed ID: 18598420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spatial summation properties for magnocellular and parvocellular pathways in glaucoma.
    Battista J; Badcock DR; McKendrick AM
    Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1221-6. PubMed ID: 18936145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pulse and steady-pedestal contrast discrimination: effect of spatial parameters.
    Smith VC; Sun VC; Pokorny J
    Vision Res; 2001 Jul; 41(16):2079-88. PubMed ID: 11403792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Visual streams and shifting attention.
    Brown JM
    Prog Brain Res; 2009; 176():47-63. PubMed ID: 19733749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of the magnocellular pathway in serial deployment of visual attention.
    Cheng A; Eysel UT; Vidyasagar TR
    Eur J Neurosci; 2004 Oct; 20(8):2188-92. PubMed ID: 15450098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Foveal contrast processing of increment and decrement targets is equivalently reduced in glaucoma.
    Sampson GP; Badcock DR; Walland MJ; McKendrick AM
    Br J Ophthalmol; 2008 Sep; 92(9):1287-92. PubMed ID: 18614574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metacontrast, target recovery, and the magno- and parvocellular systems: a perspective.
    Skottun BC; Skoyles JR
    Vis Neurosci; 2007; 24(2):177-81. PubMed ID: 17640408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of red surrounds on visual magnocellular and parvocellular cortical processing and perception.
    Hugrass L; Verhellen T; Morrall-Earney E; Mallon C; Crewther DP
    J Vis; 2018 Apr; 18(4):8. PubMed ID: 29621385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Further Examination of the Pulsed- and Steady-Pedestal Paradigms under Hypothetical Parvocellular- and Magnocellular-Biased Conditions.
    Song J; Breitmeyer BG; Brown JM
    Vision (Basel); 2024 Apr; 8(2):. PubMed ID: 38804349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contrast sensitivity changes due to glaucoma and normal aging: low-spatial-frequency losses in both magnocellular and parvocellular pathways.
    McKendrick AM; Sampson GP; Walland MJ; Badcock DR
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):2115-22. PubMed ID: 17460269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deficits in temporal integration for contrast processing in retinitis pigmentosa.
    Alexander KR; Barnes CS; Fishman GA
    Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):3163-9. PubMed ID: 12824267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.